1 March 2020 - It's a step forward but there's a long way to go, says advocate.
As of Sunday, more Albertans with cystic fibrosis will have access to what's described as a life-changing drug.
On Saturday — rare disease awareness day — the province announced it was expanding coverage for Kalydeco, starting March 1.
The twice-daily drug, which goes by the generic name ivacaftor, can cost about $300,000 a year.